Azenta Inc (AZTA) Stock Price, Quote & News

Company Profile

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates through Sample Management Solutions and Multiomics segments. The Sample Management Solutions segment provides sample management products and services, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 888 229 3682

Website: www.azenta.com

Address:

200 Summit Drive, 6th Floor, Burlington, United States

Jhoooon Jul. 2 at 4:03 PM

$AZTA promising

0 · Reply

NEWBTrader96 Jul. 1 at 5:04 PM

$AZTA nice 17% since this post, +43% since buying the drop week after earnings.

0 · Reply

Snipertradesexpert Jul. 1 at 3:11 PM

$AZTA 17 JUL 26 $30 CALL $0.50

0 · Reply

Blockwave1 Jul. 1 at 3:10 PM

$AZTA 🌊 17 JUL 26 $30 CALL $0.50 GAP FILL PLAY + SECTOR SENTIMENT + RELATIVE STRENGTH + HIGH CONFIDENCE

0 · Reply

ApexEquityVault Jul. 1 at 3:10 PM

$AZTA 17 JUL 26 $30 CALL $0.50 GAP FILL PLAY + SECTOR SENTIMENT + RELATIVE STRENGTH (NFA)

0 · Reply

liamsniperalert Jul. 1 at 3:10 PM

$AZTA 17 JUL 26 $30 CALL $0.50 GAP FILL PLAY + SECTOR SENTIMENT + RELATIVE STRENGTH

0 · Reply

SuperGreenToday Jun. 10 at 3:58 PM

$AZTA Share Price: $22.81 Contract Selected: Dec 18, 2026 $20 Calls Buy Zone: $4.33 – $5.35 Target Zone: $8.06 – $9.85 Potential Upside: 75% ROI Time to Expiration: 190 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

NEWBTrader96 Jun. 9 at 6:28 PM

$AZTA biggest competitor got marked as a Chinese military company! They’re gonna gain marketshare 👀 in for a recovery to 30-40 by eoy

0 · Reply

ApexEquityVault May. 28 at 2:52 PM

$AZTA ADDED HEAVY!!

0 · Reply

Blockwave1 May. 28 at 2:52 PM

$AZTA 🚨 18 JUN 26 $25 CALL $0.70 HUGE GAP ABOVE + SECTOR SENTIMENT + HIGH CONFIDENCE

0 · Reply

Azenta Publishes 2025 Environmental, Social, and Governance (ESG) Report

May 7, 2026, 2:39 PM EDT - 2 months ago

Azenta, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

May 6, 2026, 8:30 AM EDT - 2 months ago

Azenta Earnings Call Transcript: Q2 2026

May 6, 2026, 8:30 AM EDT - 2 months ago

Azenta Earnings release: Q2 2026

May 6, 2026, 8:30 AM EDT - 2 months ago

Azenta Slides: Q2 2026

May 6, 2026, 8:30 AM EDT - 2 months ago

Azenta Quarterly report: Q2 2026

May 5, 2026, 4:30 PM EDT - 2 months ago

Azenta Reports Second Quarter Results for Fiscal 2026, Ended March 31, 2026, Updates Full Year Fiscal 2026 Guidance, and Extends Long-Range Plan to 2029

Apr 29, 2026, 4:06 PM EDT - 2 months ago

Azenta Announces Fiscal 2026 Second Quarter Conference Call and Webcast

Apr 7, 2026, 8:15 AM EDT - 3 months ago

Azenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics Execution

2026-04-06T12:08:13.000Z - 3 months ago

Azenta price target lowered to $35 from $45 at Evercore ISI

2026-04-01T18:00:18.000Z - 3 months ago

Azenta price target lowered to $35 from $40 at Jefferies

Mar 10, 2026, 10:00 AM EDT - 4 months ago

Azenta Transcript: M&A announcement

Mar 10, 2026, 10:00 AM EDT - 4 months ago

Azenta Press release: M&A announcement

Mar 10, 2026, 10:00 AM EDT - 4 months ago

Azenta Slides: M&A announcement

Mar 4, 2026, 9:11 AM EST - 4 months ago

Azenta Completes Strategic Acquisition of UK Biocentre Limited, to Expand Biorepository Capabilities

Mar 3, 2026, 4:00 PM EST - 4 months ago

Azenta Transcript: 47th Annual Raymond James Institutional Investor Conference

Mar 3, 2026, 4:00 PM EST - 4 months ago

Azenta Slides: 47th Annual Raymond James Institutional Investor Conference

Feb 24, 2026, 4:05 PM EST - 4 months ago

Azenta to Participate in Raymond James 47th Annual Institutional Investor Conference

2026-02-09T21:16:38.000Z - 5 months ago

Azenta, Frontier Space announce strategic partnership

Feb 9, 2026, 4:05 PM EST - 5 months ago

Azenta Life Sciences and Frontier Space Announce Strategic Partnership to Advance Space-Based Life Sciences Research Infrastructure

2026-02-05T13:15:20.000Z - 5 months ago

Azenta price target lowered to $45 from $50 at Evercore ISI

2026-02-04T19:10:26.000Z - 5 months ago

Azenta price target lowered to $30 from $39 at TD Cowen

Feb 4, 2026, 8:30 AM EST - 5 months ago

Azenta Earnings Call Transcript: Q1 2026

Feb 4, 2026, 8:30 AM EST - 5 months ago

Azenta Quarterly report: Q1 2026

Feb 4, 2026, 8:30 AM EST - 5 months ago

Azenta Earnings release: Q1 2026

Feb 4, 2026, 8:30 AM EST - 5 months ago

Azenta Slides: Q1 2026

2026-02-04T12:00:54.000Z - 5 months ago

Azenta reports Q1 EPS 9c, consensus 13c

2026-02-04T12:00:32.000Z - 5 months ago

Azenta backs FY26 organic revenue view 3%-5%

Feb 4, 2026, 6:30 AM EST - 5 months ago

Azenta Reports First Quarter Results for Fiscal 2026, Ended December 31, 2025

Jan 28, 2026, 9:00 AM EST - 5 months ago

Azenta Transcript: AGM 2026

Jan 21, 2026, 4:05 PM EST - 5 months ago

Azenta Announces Fiscal 2026 First Quarter Conference Call and Webcast

2026-01-08T14:43:17.000Z - 6 months ago

Azenta price target raised to $39 from $35 at TD Cowen

2026-01-08T14:35:24.000Z - 6 months ago

Azenta price target raised to $39 from $35 at TD Cowen

2026-01-05T11:42:33.000Z - 6 months ago

Evercore ISI upgrades four, downgrades six in MedTech and Tools

A AVTR BLCO EXAS GH HOLX IRTC

2026-01-05T11:20:32.000Z - 6 months ago

Azenta upgraded to Outperform from In Line at Evercore ISI

2025-12-29T13:05:32.000Z - 6 months ago

Azenta enters agreement for sale of B Medical Systems to THELEMA for $63M

Dec 29, 2025, 8:00 AM EST - 6 months ago

Azenta Enters Definitive Agreement for the Sale of its B Medical Systems Business to THELEMA S.À R.L.

2025-12-19T12:51:17.000Z - 7 months ago

Azenta price target raised to $44 from $42 at Needham

Dec 19, 2025, 7:00 AM EST - 7 months ago

Azenta Proxy statement: Proxy Filing

Dec 18, 2025, 7:00 AM EST - 7 months ago

Azenta Proxy statement: Proxy Filing

Dec 18, 2025, 7:00 AM EST - 7 months ago

Azenta Proxy statement: Proxy Filing

2025-12-10T17:45:14.000Z - 7 months ago

Azenta authorizes $250M share repurchase program

Dec 10, 2025, 12:45 PM EST - 7 months ago

Azenta Transcript: Investor Day 2025

Dec 10, 2025, 12:45 PM EST - 7 months ago

Azenta Slides: FY 2025

Dec 10, 2025, 12:43 PM EST - 7 months ago

Azenta Authorizes $250 Million Share Repurchase Program

2025-12-10T15:45:20.000Z - 7 months ago

Azenta to host investor day

2025-11-25T16:35:20.000Z - 7 months ago

Azenta price target raised to $45 from $35 at Raymond James

2025-11-24T12:25:09.000Z - 7 months ago

Azenta upgraded to Hold from Sell at Nephron Research

Nov 21, 2025, 8:30 AM EST - 8 months ago

Azenta Earnings Call Transcript: Q4 2025

Nov 21, 2025, 8:30 AM EST - 8 months ago

Azenta Annual report: Q4 2025

Nov 21, 2025, 8:30 AM EST - 8 months ago

Azenta Earnings release: Q4 2025

Nov 21, 2025, 8:30 AM EST - 8 months ago

Azenta Slides: Q4 2025

Nov 21, 2025, 6:30 AM EST - 8 months ago

Azenta Reports Fourth Quarter and Full Year Fiscal 2025 Results, Ended September 30, 2025

Nov 12, 2025, 4:05 PM EST - 8 months ago

Azenta Announces Fiscal 2025 Fourth Quarter and Full Year Conference Call and Webcast

Nov 4, 2025, 4:05 PM EST - 8 months ago

Azenta Life Sciences Partners with PRECEDE Foundation to Advance Early Detection of Pancreatic Cancer

Oct 15, 2025, 8:00 AM EDT - 9 months ago

Azenta to Host Investor Day at its Biorepository Facility in Indianapolis, Indiana

Aug 5, 2025, 8:30 AM EDT - 11 months ago

Azenta Earnings Call Transcript: Q3 2025

Aug 5, 2025, 8:30 AM EDT - 11 months ago

Azenta Quarterly report: Q3 2025

Aug 5, 2025, 8:30 AM EDT - 11 months ago

Azenta Earnings release: Q3 2025

Aug 5, 2025, 8:30 AM EDT - 11 months ago

Azenta Slides: Q3 2025

Aug 5, 2025, 6:30 AM EDT - 11 months ago

Azenta Reports Third Quarter Results for Fiscal 2025, Ended June 30, 2025; Reiterates Full Year Fiscal 2025 Guidance

Jul 31, 2025, 4:05 PM EDT - 1 year ago

Azenta Life Sciences Partners with Frenova, a Division of Fresenius Medical Care, and Nephronomics to Advance Genomic Research in Nephrology

Jul 31, 2025, 8:30 AM EDT - 1 year ago

Fresenius Medical Care's Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease Care

Jul 30, 2025, 4:05 PM EDT - 1 year ago

Azenta to Participate in 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference

Jul 23, 2025, 4:05 PM EDT - 1 year ago

Azenta Announces Fiscal 2025 Third Quarter Earnings Conference Call and Webcast

May 13, 2025, 4:05 PM EDT - 1 year ago

Azenta Life Sciences and Form Bio Announce Strategic Partnership to Advance AAV Gene Therapy Development

May 7, 2025, 8:30 AM EDT - 1 year ago

Azenta Earnings Call Transcript: Q2 2025

May 7, 2025, 8:30 AM EDT - 1 year ago

Azenta Quarterly report: Q2 2025

May 7, 2025, 8:30 AM EDT - 1 year ago

Azenta Earnings release: Q2 2025

May 7, 2025, 8:30 AM EDT - 1 year ago

Azenta Slides: Q2 2025

May 7, 2025, 6:30 AM EDT - 1 year ago

Azenta Reports Second Quarter Results for Fiscal 2025, Ended March 31, 2025

Apr 24, 2025, 4:15 PM EDT - 1 year ago

Azenta Announces Fiscal 2025 Second Quarter Earnings Conference Call and Webcast

Mar 24, 2025, 4:05 PM EDT - 1 year ago

Azenta Publishes its 2024 Environmental, Social, & Governance (ESG) Report

Mar 19, 2025, 10:30 AM EDT - 1 year ago

Azenta Transcript: KeyBanc Annual Healthcare Forum 2025

Mar 10, 2025, 5:05 PM EDT - 1 year ago

Azenta to Participate in the Virtual KeyBanc Capital Markets Healthcare Forum

Feb 5, 2025, 8:30 AM EST - 1 year ago

Azenta Earnings Call Transcript: Q1 2025

Feb 5, 2025, 8:30 AM EST - 1 year ago

Azenta Quarterly report: Q1 2025

Feb 5, 2025, 8:30 AM EST - 1 year ago

Azenta Earnings release: Q1 2025

Feb 5, 2025, 8:30 AM EST - 1 year ago

Azenta Slides: Q1 2025

Feb 5, 2025, 7:00 AM EST - 1 year ago

Azenta Reports First Quarter Results for Fiscal 2025, Ended December 31, 2024

Jan 30, 2025, 4:05 PM EST - 1 year ago

Azenta Announces the Election of Dipal Doshi to its Board of Directors

TRDA

Jan 27, 2025, 4:05 PM EST - 1 year ago

Azenta Announces Fiscal 2025 First Quarter Earnings Conference Call and Webcast

Jan 23, 2025, 4:05 PM EST - 1 year ago

UK Biocentre Selects the Azenta Life Sciences BioArc Ultra Automated Storage System to Advance Research Excellence

Dec 17, 2024, 7:00 AM EST - 1 year ago

Azenta Proxy statement: Proxy Filing

Dec 17, 2024, 7:00 AM EST - 1 year ago

Azenta Proxy statement: Proxy Filing

Nov 22, 2024, 6:35 PM EST - 1 year ago

Final Trade: BABA, GOOGL, AZTA, GDX

GDX GOOG GOOGL BABA

Nov 20, 2024, 2:00 PM EST - 1 year ago

Azenta Transcript: Stephens 26th Annual Investment Conference | NASH2024

Nov 19, 2024, 5:56 PM EST - 1 year ago

Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600

CON ENV FLEX MYE SEM

Nov 14, 2024, 8:00 AM EST - 1 year ago

Azenta to Participate in Stephens Annual Investment Conference

Nov 12, 2024, 4:30 PM EST - 1 year ago

Azenta Earnings Call Transcript: Q4 2024

Nov 12, 2024, 4:30 PM EST - 1 year ago

Azenta Annual report: Q4 2024

Nov 12, 2024, 4:30 PM EST - 1 year ago

Azenta Earnings release: Q4 2024

Nov 12, 2024, 4:30 PM EST - 1 year ago

Azenta Slides: Q4 2024

Nov 12, 2024, 4:05 PM EST - 1 year ago

Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFO

Jhoooon Jul. 2 at 4:03 PM

$AZTA promising

0 · Reply

NEWBTrader96 Jul. 1 at 5:04 PM

$AZTA nice 17% since this post, +43% since buying the drop week after earnings.

0 · Reply

Snipertradesexpert Jul. 1 at 3:11 PM

$AZTA 17 JUL 26 $30 CALL $0.50

0 · Reply

Blockwave1 Jul. 1 at 3:10 PM

$AZTA 🌊 17 JUL 26 $30 CALL $0.50 GAP FILL PLAY + SECTOR SENTIMENT + RELATIVE STRENGTH + HIGH CONFIDENCE

0 · Reply

ApexEquityVault Jul. 1 at 3:10 PM

$AZTA 17 JUL 26 $30 CALL $0.50 GAP FILL PLAY + SECTOR SENTIMENT + RELATIVE STRENGTH (NFA)

0 · Reply

liamsniperalert Jul. 1 at 3:10 PM

$AZTA 17 JUL 26 $30 CALL $0.50 GAP FILL PLAY + SECTOR SENTIMENT + RELATIVE STRENGTH

0 · Reply

SuperGreenToday Jun. 10 at 3:58 PM

0 · Reply

NEWBTrader96 Jun. 9 at 6:28 PM

$AZTA biggest competitor got marked as a Chinese military company! They’re gonna gain marketshare 👀 in for a recovery to 30-40 by eoy

0 · Reply

ApexEquityVault May. 28 at 2:52 PM

$AZTA ADDED HEAVY!!

0 · Reply

Blockwave1 May. 28 at 2:52 PM

$AZTA 🚨 18 JUN 26 $25 CALL $0.70 HUGE GAP ABOVE + SECTOR SENTIMENT + HIGH CONFIDENCE

0 · Reply

ApexEquityVault May. 28 at 2:52 PM

$AZTA 18 JUN 26 $25 CALL $0.70 HUGE GAP ABOVE + SECTOR SENTIMENT + HIGH CONFIDENCE

0 · Reply

OnlyFibs May. 25 at 10:16 PM

$AZTA is attempting to build a floor and break its descending trendline after a catastrophic earnings gap-down on the back of slashed guidance and a massive impairment charge. 🌊 This is a high-risk structural reset for the life sciences giant. With the massive Q2 margin collapse fully priced in and the stock taking a historic haircut, bottom-fishers are actively positioning for a mean-reversion squeeze. However, management's lowered full-year outlook keeps the fundamental overhang incredibly heavy, leaving very little room for error on the immediate roadmap. 🎯 🐂 Bulls want to hold the 17.60 baseline to force a clean daily close over 20.39 targeting the heavy 22.67 supply shelf 🐻 Bears need to crack 17.60 to kill the dead-cat bounce and trigger a new wave of capitulation 📊 Lean NEUTRAL. #azta #trading #hovdid

0 · Reply

OnlyFibs May. 23 at 5:31 AM

$AZTA putting in a flat capitulation base right at the $18.50 demand floor after a heavy fiscal Q2 guidance reset 🌋 Life sciences play holds an absolute fortress balance sheet: $580M in pure cash and ZERO debt. Current market cap heavily discounts assets. ... 🐻 Bears need a break under $18.50 to test the deeper $15.00 cash floor. 📊 Lean neutral-to-BULLISH. Severe execution shortfalls are out, but the massive cash cushion de-risks the downside. Watch for the turn. #AZTA #hovdid

0 · Reply

OnlyFibs May. 21 at 2:29 AM

$AZTA down from $41 to $15.94 and now bouncing 5.15% off capitulation volume. Azenta life sciences automation — sample management, genomic services, biobanking. Volume exhaustion at the lows confirmed the bottom. ITM $17.5 call sweep just hit with spot at $17.86. RSI launching from near 20. Someone decided the floor is in. 🐂 $18.57 holds and $19.60 then $22 then $24.24 happen in sequence. Capitulation volume + ITM call sweep + RSI recovery = three reasons to pay attention. 🐻 $17.60 loses and the bounce was just relief. $16.94 then $15.94 retest. Life sciences spending still under pressure. ⚠️ ITM call sweep same day as the capitulation volume bounce. That's not random timing. Bottom volume printed. Sweep confirmed. Recovery has a case. #AZTA #Azenta #LifeSciences #OptionsFlow #TechnicalAnalysis #hovdid

0 · Reply

OnlyFibs May. 20 at 2:34 AM

$AZTA — Azenta. Life sciences automation, biobanking, genomics services. Has spent 4 years in one of the most brutal downtrends on any chart — $90 to $7.94. Multi-decade low hit. Gap from 2016 finally filled. Volume exhaustion on the capitulation wick. And today it's up 8.68%. 🐂 Gap fill + volume exhaustion at decade lows = capitulation bottom thesis. $19 reclaim → $25–29. Activist or strategic catalyst = violent squeeze. 🐻 Every rally in this downtrend has been sold. Pink trendline from 2021 is still miles above. Life sciences spending still under pressure. ⚠️ $7.94 decade low + gap fill + 8.68% bounce today. Either the bottom is in or this is a dead cat. Volume on the flush suggests real capitulation. #AZTA #Azenta #LifeSciences #Biotech #TechnicalAnalysis #hovdid

0 · Reply

topstockalerts May. 20 at 1:11 AM

$AZTA the market is rewarding anyone who stayed patient.

0 · Reply

FilingTracker May. 19 at 8:16 PM

$AZTA Insider purchase: https://www.sec.gov/Archives/edgar/data/933974/000119312526230764/xslF345X06/ownership.xml

0 · Reply

BillionerOfKing May. 11 at 12:26 PM

$AZTA Current Stock Price: $19.22 Contracts to trade: $20.0 AZTA May 15 2026 Call Entry: $1.01 Exit: $1.39 ROI: 38% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

NEWBTrader96 May. 6 at 1:23 PM

$AZTA loading up 12 shares after the crash following bad earnings.

0 · Reply

Estimize May. 6 at 12:39 AM

$AZTA reported -0.04 EPS and 144.80 revenue for Q2. http://www.estimize.com/intro/azta?chart=historical&metric_name=eps&utm_content=AZTA&ut

0 · Reply

StocktwitsEarnings May. 5 at 8:55 PM

$AZTA Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$3.49 down -772.50% YoY • Reported revenue of $144.79M up 0.96% YoY • Azenta expects FY'26 total reported revenue from continuing operations to be $603M-$621M. Organic revenue is now projected down 2% to up 1%, a reduction from prior guidance, and Adjusted EBITDA margin is expected down 125 bps to flat.

0 · Reply

BillionerOfKing May. 4 at 9:01 PM

$AZTA Current Stock Price: $24.32 Contracts to trade: $25.0 AZTA May 15 2026 Call Entry: $0.05 Exit: $0.09 ROI: 86% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

Market Cap	1.19B
Revenue (ttm)	593.82M
Net Income (ttm)	-55.76M
EPS (ttm)	N/A
PE Ratio	58.20
Forward PE	N/A
Profit Margin	-9.39%
Debt to Equity Ratio	0.00

Volume	518,000
Avg Vol	1,164,936
Day's Range	N/A - N/A
Shares Out	46.09M
Stochastic %K	76%
Beta	1.37
Analysts	Sell
Price Target	$26.20